[The interferon status in diabetes mellitus]

Area of Science:

• Immunology
• Endocrinology
• Virology

Background:

• Interferons (IFNs) are crucial cytokines in antiviral immunity.
• Diabetes mellitus (DM) is a metabolic disorder that can affect immune function.
• Previous research suggests potential links between immune dysregulation and DM complications.

Purpose of the Study:

• To investigate the interferon status in patients with diabetes mellitus.
• To correlate interferon levels with disease severity and duration.
• To assess the impact of metabolic compensation on interferon profiles.

Main Methods:

• Analysis of blood serum interferon levels in 54 diabetes mellitus patients.
• Assessment of leukocyte inhibition of alpha-interferon (α-IFN) production.
• Measurement of gamma-interferon (γ-IFN) synthesis.
• Evaluation of interferon status in relation to disease severity, duration, and metabolic control.

Main Results:

• Patients with diabetes mellitus exhibited high blood serum interferon levels.
• Leukocyte inhibition of α-IFN production was observed, alongside moderate γ-IFN synthesis.
• More pronounced alterations in interferon status were found in severe, long-standing insulin-dependent diabetes mellitus complicated by angiopathies.
• Metabolic process compensation did not significantly correlate with the interferon status.
• Interferon level variations occurred in 30% of patients during the observation period.

Conclusions:

• Diabetes mellitus is associated with significant alterations in interferon status, characterized by elevated serum interferon and dysregulated α-IFN and γ-IFN production.
• Severe and long-duration insulin-dependent diabetes mellitus with angiopathies shows the most marked interferon dysregulation.
• Interferon status appears independent of metabolic compensation in diabetes mellitus patients.